To determine whether CD161-expressing T cells are associated with the development of GVHD, statistical analysis was performed between relative and absolute cell counts of CD161+CD4+ and CD161hiCD8+ T cells measured in the circulation of patients at 3 months after allo-SCT and their GVHD status. This evidence concerns the gene CD4 and graft versus host disease.